Viscogliosi Bros.

Spine BioPharma focuses on developing non-surgical therapies aimed at alleviating back pain and restoring functionality without the use of opioids. The company’s pipeline includes treatments specifically designed to address degenerative spine diseases, with the primary goal of providing pain relief, enhancing functional capabilities, and potentially halting disease progression. Its lead candidate targets degenerative disc disease, offering clinically proven benefits that improve the quality of life for individuals affected by these conditions. By prioritizing safe and effective therapeutic solutions, Spine BioPharma seeks to positively impact the lives of millions suffering from chronic back pain.

Companion Spine is a spine care company focused on delivering interventional therapies and technologies aimed at alleviating back pain with minimal disruption and discomfort. The company specializes in diagnostic and medical implant products that facilitate the immediate and accurate identification of spinal conditions. By addressing the root causes of pain, Companion Spine enables patients to manage their ailments while maintaining full mobility of the spine, ultimately enhancing their quality of life.

Spine BioPharma focuses on developing non-surgical therapies aimed at alleviating back pain and restoring functionality without the use of opioids. The company’s pipeline includes treatments specifically designed to address degenerative spine diseases, with the primary goal of providing pain relief, enhancing functional capabilities, and potentially halting disease progression. Its lead candidate targets degenerative disc disease, offering clinically proven benefits that improve the quality of life for individuals affected by these conditions. By prioritizing safe and effective therapeutic solutions, Spine BioPharma seeks to positively impact the lives of millions suffering from chronic back pain.

Small Bone Innovations (SBi) specializes in the development and manufacturing of medical devices aimed at small bones and joints, with a particular emphasis on trauma and arthroplasty. The company provides a range of implants designed for various anatomical areas, including the thumb, hand, wrist, elbow, foot, and ankle. Its product offerings include implants specifically designed to treat basal joint arthritis and those intended for replacing anatomic joint surfaces. SBi's innovations focus on preserving bone structure and minimizing disruption to collateral ligament origins and insertions, as well as soft skeletal implants, thereby enhancing surgical outcomes for patients with joint-related conditions.

Small Bone Innovations (SBi) specializes in the development and manufacturing of medical devices aimed at small bones and joints, with a particular emphasis on trauma and arthroplasty. The company provides a range of implants designed for various anatomical areas, including the thumb, hand, wrist, elbow, foot, and ankle. Its product offerings include implants specifically designed to treat basal joint arthritis and those intended for replacing anatomic joint surfaces. SBi's innovations focus on preserving bone structure and minimizing disruption to collateral ligament origins and insertions, as well as soft skeletal implants, thereby enhancing surgical outcomes for patients with joint-related conditions.

Small Bone Innovations (SBi) specializes in the development and manufacturing of medical devices aimed at small bones and joints, with a particular emphasis on trauma and arthroplasty. The company provides a range of implants designed for various anatomical areas, including the thumb, hand, wrist, elbow, foot, and ankle. Its product offerings include implants specifically designed to treat basal joint arthritis and those intended for replacing anatomic joint surfaces. SBi's innovations focus on preserving bone structure and minimizing disruption to collateral ligament origins and insertions, as well as soft skeletal implants, thereby enhancing surgical outcomes for patients with joint-related conditions.

Spine Next is a biotech company that manufactures and markets orthopedic spinal implant devices for spinal fusion surgeries. Spine Next is a France-based company that was founded in 1999 and the company was acquired by Abbott on October 25, 2004.

Raymedica, Inc. is a medical device manufacturer based in Minneapolis, Minnesota, focused on developing innovative solutions for the surgical treatment of low back pain, particularly in patients who have not found relief through conservative care. The company is dedicated to enhancing the technology created by its founder, Charles D. Ray, M.D. Raymedica's primary product is the PDN® prosthetic disc nucleus, designed to address low back pain due to degenerative disc disease. This device is surgically implanted into the evacuated nucleus disc space of the lumbar spine, where it aims to increase or maintain disc height, thereby restoring normal biomechanics and alleviating pain. Through its advancements in nucleus arthroplasty motion preservation technology, Raymedica seeks to improve the quality of life for patients worldwide suffering from disc-related issues.